Dongsheng Ouyang Selected Research

1- (4- fluorophenyl)- 3- (3- (4- fluorophenyl)- 4- hydroxybut- 2- enyl)- 4- (4- hydroxyphenyl)- 2- azetidinone

1/2022

The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dongsheng Ouyang Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 01/2020
3	Diabetic Nephropathies (Diabetic Nephropathy) 08/2021 - 01/2021
3	Chemical and Drug Induced Liver Injury 04/2021 - 01/2019
3	Rheumatoid Arthritis 07/2019 - 01/2017
2	Heart Failure 01/2022 - 01/2020
2	Pathologic Constriction (Stenosis) 11/2020 - 01/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2020
2	Epilepsy (Aura) 01/2020 - 09/2017
2	Status Epilepticus (Complex Partial Status Epilepticus) 12/2017 - 09/2017
1	Hypercholesterolemia 01/2022
1	Depressive Disorder (Melancholia) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Hypersensitivity (Allergy) 04/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Hypertension (High Blood Pressure) 11/2020
1	Coronary Stenosis (Coronary Artery Stenosis) 11/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 03/2019
1	Cognitive Dysfunction 03/2019
1	Diabetes Complications 01/2019
1	Myocardial Infarction 04/2018
1	Body Weight (Weight, Body) 03/2015
1	Hyperlipidemias (Hyperlipidemia) 01/2013
1	Essential Hypertension 02/2012
1	Lung Neoplasms (Lung Cancer) 08/2010

Drug/Important Bio-Agent (IBA)

5	ginsenoside M1IBA 01/2022 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2019
5	Pharmaceutical PreparationsIBA 04/2021 - 01/2017
3	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 08/2021 - 01/2021
2	Choline (Choline Chloride)IBA 11/2020 - 01/2020
2	Betaine (C.B.B.)FDA Link 01/2020 - 01/2020
2	Aldehyde Reductase (Aldose Reductase)IBA 01/2019 - 02/2012
2	Pilocarpine (Ocusert)FDA LinkGeneric 12/2017 - 09/2017
2	Lithium ChlorideIBA 12/2017 - 09/2017
2	CholesterolIBA 03/2015 - 01/2013
1	Carvedilol (Coreg)FDA LinkGeneric 01/2022
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2022
1	Doxepin (Mareen)FDA LinkGeneric 01/2022
1	1- (4- fluorophenyl)- 3- (3- (4- fluorophenyl)- 4- hydroxybut- 2- enyl)- 4- (4- hydroxyphenyl)- 2- azetidinoneIBA 01/2022
1	HLA-B Antigens (HLA-B)IBA 04/2021
1	Carbamazepine (Tegretol)FDA LinkGeneric 04/2021
1	pazopanib FDA Link 04/2021
1	abacavir (Ziagen)FDA Link 04/2021
1	HLA-B57 antigenIBA 04/2021
1	HLA-A31 antigenIBA 04/2021
1	Floxacillin (Flucloxacillin)IBA 04/2021
1	NucleotidesIBA 01/2021
1	InflammasomesIBA 01/2021
1	PyrinIBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Antineoplastic AntimetabolitesIBA 01/2021
1	InterleukinsIBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	AntioxidantsIBA 01/2020
1	Everolimus FDA Link 01/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2020
1	Biological ProductsIBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	aucubinIBA 01/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	Peptides (Polypeptides)IBA 03/2019
1	sorbinilIBA 01/2019
1	Coffee FDA Link 04/2018
1	G-Protein-Coupled Receptor Kinase 5IBA 12/2017
1	Purinergic P2X7 ReceptorsIBA 09/2017
1	Triglycerides (Triacylglycerol)IBA 03/2015
1	HDL CholesterolIBA 03/2015
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2013
1	2-acylglycerol O-acyltransferaseIBA 01/2013
1	LipidsIBA 01/2013
1	DiglyceridesIBA 01/2013
1	AcyltransferasesIBA 01/2013
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013
1	Proprotein Convertase 9IBA 01/2013
1	microsomal triglyceride transfer proteinIBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Eukaryotic Initiation Factor-3IBA 08/2010
1	Docetaxel (Taxotere)FDA Link 08/2010

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2021
1	Intraperitoneal Injections 09/2017